ArticlemSystems2023
Bayesian sequential approach to monitor COVID-19 variants through test positivity rate from wastewater.
Article in mSystems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Academic institution extensive, building-by-building wastewater-based surveillance platform for SARS-CoV-2 monitoring, clinical data correlation, and potential national proxy.PLOS global public health · 2025Article
- Human viral nucleic acids concentrations in wastewater solids from Central and Coastal California USA.Scientific data · 2023Article
- Bayesian sequential approach to monitor COVID-19 variants through positivity rate from wastewater.medRxiv : the preprint server for health sciences · 2023Article
- Data-driven estimation of the instantaneous reproduction number and growth rates for the 2022 monkeypox outbreak in Europe.PloS one · 2023Article
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Deployment of clinical testing on a massive scale was an essential control measure for curtailing the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the magnitude of the COVID-19 (coronavirus disease 2019) pandemic during its waves. As the pandemic progressed, new preventive and surveillance mechanisms emerged. Implementation of vaccine programs, wastewater (WW) surveillance, and at-home COVID-19 antigen tests reduced the demand for mass SARS-CoV-2 testing. Unfortunately, reductions in testing and test reporting rates also reduced the availability of public health data to support decision-making. This paper proposes a sequential Bayesian approach to estimate the COVID-19 test positivity rate (TPR) using SARS-CoV-2 RNA concentrations measured in WW through an adaptive scheme incorporating changes in virus dynamics. The proposed modeling framework was applied to WW surveillance data from two WW treatment plants in California; the City of Davis and the University of California, Davis campus. TPR estimates are used to compute thresholds for WW data using the Centers for Disease Control and Prevention thresholds for low (<5% TPR), moderate (5%-8% TPR), substantial (8%-10% TPR), and high (>10% TPR) transmission. The effective reproductive number estimates are calculated using TPR estimates from the WW data. This approach provides insights into the dynamics of the virus evolution and an analytical framework that combines different data sources to continue monitoring COVID-19 trends. These results can provide public health guidance to reduce the burden of future outbreaks as new variants continue to emerge. IMPORTANCE We propose a statistical model to correlate WW with TPR to monitor COVID-19 trends and to help overcome the limitations of relying only on clinical case detection. We pose an adaptive scheme to model the nonautonomous nature of the prolonged COVID-19 pandemic. The TPR is modeled through a Bayesian sequential approach with a beta regression model using SARS-CoV-2 RNA concentrations measured in WW as a covariable. The resulting model allows us to compute TPR based on WW measurements and incorporates changes in viral transmission dynamics through an adaptive scheme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.